The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy

2005601 citationsJournal Articlebronze Open Access

Authors

Clara Klerk · Maastricht University Medical Centre

Susanne M. Smorenburg · Maastricht University Medical Centre

Hans-Martin Otten · Maastricht University Medical Centre

Anthonie W.A. Lensing · Maastricht University Medical Centre

Martin H. Prins · Maastricht University Medical Centre

Franco Piovella · Maastricht University Medical Centre

Paolo Prandoni

Abstract

A brief course of subcutaneous low molecular weight heparin favorably influences the survival in patients with advanced malignancy and deserves additional clinical evaluation.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Cancer Treatment and Pharmacology Chemotherapy-related skin toxicity

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 23, Issue 10, pp. 2130-2135

DOI: 10.1200/jco.2005.03.134

Field-Weighted Citation Impact: 39.11